Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lilia Bouzit"'
Autor:
Gudrun Böhmdorfer, Shriya Sethuraman, M Jordan Rowley, Michal Krzyszton, M Hafiz Rothi, Lilia Bouzit, Andrzej T Wierzbicki
Publikováno v:
eLife, Vol 5 (2016)
RNA-mediated transcriptional gene silencing is a conserved process where small RNAs target transposons and other sequences for repression by establishing chromatin modifications. A central element of this process are long non-coding RNAs (lncRNA), wh
Externí odkaz:
https://doaj.org/article/2fd2ef24e3fb48bfa1c98540afe2f95f
Autor:
Vicki K. Wing, Philippe Martin, Aaron Galaznik, Li Shi, Emelly Rusli, Lilia Bouzit, Chelsea Vigna, Caleb Ball, Rahul Jain
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:HSR22-179
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38b62b171c28b83c3ed3e8057af57d08
https://doi.org/10.6004/jnccn.2021.7199
https://doi.org/10.6004/jnccn.2021.7199
Autor:
Elizabeth W. Karlson, Lilia Bouzit, Susan Malspeis, Kazuki Yoshida, Karen H. Costenbader, Jeffrey A. Sparks, Jing Cui
Publikováno v:
Semin Arthritis Rheum
Objective We sought to improve seropositive rheumatoid arthritis (RA) risk prediction using a novel weighted genetic risk score (wGRS) and preclinical plasma metabolites associated with RA risk. Predictive performance was compared to previously valid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8084390d50f61a3a3bbaab561bf1d16
https://doi.org/10.1016/j.semarthrit.2021.07.006
https://doi.org/10.1016/j.semarthrit.2021.07.006
Autor:
Jeremy W. Snider, Brennan Beal, Lilia Bouzit, Cheryl Cho-Phan, Leah Comment, Garrett Frampton, Tamara Snow
Publikováno v:
Cancer Research. 83:4257-4257
Background Contemporary evidence on the size of biomarker-defined cancer populations is crucial for clinical and economic healthcare decision makers. Estimates can be derived from real-world data (RWD), but may be affected by biases stemming from dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::746e65448866b2fe74f87caf63ee879f
https://doi.org/10.1158/1538-7445.am2023-4257
https://doi.org/10.1158/1538-7445.am2023-4257
Autor:
Emelly Rusli, Aniketh Talwai, Vibhu Agarwal, Jacob Aptekar, Yahav Itzkovich, Aaron Galaznik, Robert Buderi, Lilia Bouzit, Alexandru Socolov
Publikováno v:
Blood. 138:4826-4826
Background: Despite the potential for durable disease remission seen with Chimeric Antigen Receptor (CAR-T) and T-Cell Receptor (TCR-T) therapies, their use is limited by the potential for acute toxicity from Cytokine-Release Syndrome (CRS).Across al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fe7cba904c1291e3cb5fb1679d6ddb8
https://doi.org/10.1182/blood-2021-149180
https://doi.org/10.1182/blood-2021-149180
